Study Data Show Safety Of Shingrix Vaccine Consistent With Prelicensure Clinical Trials.

CNN (1/31, Scutti) reports side effects for GSK’s Shingrix vaccine “in its first eight months of doctors’ office use were mostly unremarkable, but 3% of the complaints were serious, according to a Thursday report from the US Centers for Disease Control an...